Gene-environment interactions in sporadic Parkinson's disease

被引:43
作者
BenMoyal-Segal, Liat
Soreq, Hermona [1 ]
机构
[1] Hebrew Univ Jerusalem, Israel Ctr Neuronal Computat, IL-91904 Jerusalem, Israel
[2] Inst Life Sci, Dept Biol Sci, Jerusalem, Israel
关键词
acetylcholinesterase; inherited susceptibility; insecticide exposure; multigene contributions; paraoxonase; 1;
D O I
10.1111/j.1471-4159.2006.03937.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Much has been learned in recent years about the genetics of familial Parkinson's disease. However, far less is known about those malfunctioning genes which contribute to the emergence and/or progression of the vast majority of cases, the 'sporadic Parkinson's disease', which is the focus of our current review. Drastic differences in the reported prevalence of Parkinson's disease in different continents and countries suggest ethnic and/or environmental-associated multigenic contributions to this disease. Numerous association studies showing variable involvement of multiple tested genes in these distinct locations support this notion. Also, variable increases in the risk of Parkinson's disease due to exposure to agricultural insecticides indicate complex gene-environment interactions, especially when genes involved in protection from oxidative stress are explored. Further consideration of the brain regions damaged in Parkinson's disease points at the age-vulnerable cholinergic-dopaminergic balance as being involved in the emergence of sporadic Parkinson's disease in general and in the exposure-induced risks in particular. More specifically, the chromosome 7 ACHE/PON1 locus emerges as a key region controlling this sensitive balance, and animal model experiments are compatible with this concept. Future progress in the understanding of the genetics of sporadic Parkinson's disease depends on globally coordinated, multileveled studies of gene-environment interactions.
引用
收藏
页码:1740 / 1755
页数:16
相关论文
共 204 条
[21]   Genetic and environmental risk factors for Parkinson's disease in a Chinese population [J].
Chan, DKY ;
Woo, J ;
Ho, SC ;
Pang, CP ;
Law, LK ;
Ng, PW ;
Hung, WT ;
Kwok, T ;
Hui, E ;
Orr, K ;
Leung, MF ;
Kay, R .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (05) :781-784
[22]  
Chantry David, 2002, Current Drug Targets - Inflammation and Allergy, V1, P109, DOI 10.2174/1568010023344995
[23]   ENVIRONMENTAL EXPOSURES IN ELDERLY CANADIANS WITH PARKINSONS-DISEASE [J].
CHATURVEDI, S ;
OSTBYE, T ;
STOESSL, AJ ;
MERSKEY, H ;
HACHINSKI, V .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1995, 22 (03) :232-234
[24]   Prevalence of Parkinson's disease in Northwestern Italy:: Comparison of tracer methodology and clinical ascertainment of cases [J].
Chiò, A ;
Magnani, C ;
Schiffer, D .
MOVEMENT DISORDERS, 1998, 13 (03) :400-405
[25]   Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population [J].
Clarimon, J ;
Eerola, J ;
Hellström, I ;
Tienari, PJ ;
Singleton, A .
NEUROSCIENCE LETTERS, 2004, 367 (02) :168-170
[26]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[27]  
Costa P, 1997, AM J MED GENET, V74, P154, DOI 10.1002/(SICI)1096-8628(19970418)74:2<154::AID-AJMG7>3.3.CO
[28]  
2-A
[29]   Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism [J].
Costa-Mallen, P ;
Costa, LG ;
Smith-Weller, T ;
Franklin, GM ;
Swanson, PD ;
Checkoway, H .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (04) :535-537
[30]   Functional analysis of the human D-2 dopamine receptor missense variants [J].
Cravchik, A ;
Sibley, DR ;
Gejman, PV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) :26013-26017